Skip to main content
Premium Trial:

Request an Annual Quote

With Eye on Growing US Business, Oxford Gene Technology Opens New York Office

NEW YORK (GenomeWeb News) – Oxford Gene Technology announced on Tuesday the opening of an office in Tarrytown, NY, to support and grow its US business.

Specifically, the office will seek to expand OGT's CytoSure cytogenetics arrays and Genefficiency next-generation sequencing operations. OGT will provide support and training to its existing US customers at the new office, and added that sales and support positions have been created with additional positions to be created in the coming weeks.

According to the UK firm, the US is the world's largest cytogenetics market "and is critical to the development of OGT's clinical and genomic services business."

OGT provides clinical genetics and diagnostics solutions directed at molecular medicine. CytoSure and Genefficiency comprise its Clinical & Genomic Solutions business. Its other business, Diagnostic Biomarkers, uses next-generation sequencing to discover biomarkers for the early detection of cancers, such as colorectal, prostate, and pancreatic cancers, as well as systemic lupus erythematosus.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.